SCHEMBL30438540

SCHEMBL30438540

O=S(=O)(NC(c1ccc(Cl)cc1)C(F)(F)F)c1ccc2ncc(Cl)n2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 1/20 0.35
SCN5A Q14524 1/20 0.35
SCN8A Q9UQD0 1/20 0.35
PIK3CA P42336 3/20 0.34
MTOR P42345 3/20 0.34
CLK1 P49759 2/20 0.34
ALDH1A1 P00352 2/20 0.34
ALOX5AP P20292 5/20 0.33
FEN1 P39748 5/20 0.33
S1PR1 P21453 3/20 0.33
S1PR3 Q99500 1/20 0.33
SLC1A3 P43003 1/20 0.33
SLC1A2 P43004 1/20 0.33
SLC1A1 P43005 1/20 0.33
CA2 P00918 2/20 0.33
MMP2 P08253 2/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
RPS6KB1 P23443 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25703348 1.00 SCN1A (0.35) SCN1ASCN5ASCN8APIK3CAMTOR
SCHEMBL30438495 0.92 PIK3CA (0.41) SCN1ASCN5ASCN8APIK3CAMTOR
SCHEMBL25701931 0.92 PIK3CA (0.41) SCN1ASCN5ASCN8APIK3CAMTOR
SCHEMBL31529527 0.91 ALDH1A1 (0.37) SCN1ASCN5ASCN8APIK3CAMTOR
SCHEMBL25437180 0.78 PIK3CA (0.40) SCN1ASCN5ASCN8APIK3CAMTOR
SCHEMBL31529481 0.78 PIK3CA (0.40) SCN1ASCN5ASCN8APIK3CAMTOR
SCHEMBL25435602 0.78 ALDH1A1 (0.37) SCN1ASCN5ASCN8APIK3CAALDH1A1
SCHEMBL25435598 0.78 ALDH1A1 (0.37) SCN1ASCN5ASCN8APIK3CAALDH1A1
SCHEMBL31529561 0.77 BRAF (0.35) SCN1ASCN5ASCN8AALDH1A1ALOX5AP
SCHEMBL30438630 0.77 BRAF (0.35) SCN1ASCN5ASCN8AALDH1A1ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436955-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS Lario Therapeutics Limited (GB) 2024-10-02 EP disclosed
WO-2023094830-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS LARIO THERAPEUTICS LIMITED (GB) 2023-06-01 WO disclosed